Danaher Corporation

246.37-2.82-1.13%Vol 2.26M1Y Perf -1.73%
May 16th, 2022 16:03 DELAYED
BID240.00 ASK247.10
Open247.89 Previous Close246.37
Pre-Market- After-Market246.30
 - -  -0.07 -0.03%
Target Price
330.85 
Analyst Rating
Strong Buy 1.50
Potential %
34.29 
Finscreener Ranking
★★+     48.43
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     50.61
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     59.48
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★     38.11
Price Range Ratio 52W %
12.63 
Earnings Rating
Strong Buy
Market Cap179.13B 
Earnings Date
21st Apr 2022
Alpha0.01 Standard Deviation0.06
Beta0.84 

Today's Price Range

244.48249.88

52W Range

233.71333.96

5 Year PE Ratio Range

21.3068.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.46%
1 Month
-11.05%
3 Months
-8.50%
6 Months
-20.44%
1 Year
-1.73%
3 Years
87.93%
5 Years
200.82%
10 Years
380.98%

TickerPriceChg.Chg.%
DHR246.37-2.8200-1.13
AAPL145.54-1.5700-1.07
GOOG2 295.85-34.4600-1.48
MSFT261.500.38000.15
XOM90.952.09002.35
WFC42.21-0.4300-1.01
JNJ178.081.23000.70
FB200.041.42000.71
GE74.63-0.4200-0.56
JPM118.26-0.8300-0.70
Financial StrengthValueIndustryS&P 500US Markets
1.10
1.70
0.32
0.51
33.50
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
60.80
25.90
33.30
19.40
21.32
RevenueValueIndustryS&P 500US Markets
30.28B
41.65
15.37
9.03
DividendsValueIndustryS&P 500US Markets
0.41
1.00
8.76
8.85
Payout ratio10.00
Earnings HistoryEstimateReportedSurprise %
Q01 20222.652.764.15
Q04 20212.502.697.60
Q03 20212.142.3911.68
Q02 20212.042.4620.59
Q01 20211.672.5250.90
Q04 20201.842.0813.04
Q03 20201.371.7225.55
Q02 20201.061.4435.85
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.36-5.22Negative
9/2022 QR2.32-5.31Negative
12/2022 FY10.31-0.96Negative
12/2023 FY10.78-1.01Negative
Next Report Date-
Estimated EPS Next Report2.63
Estimates Count6
EPS Growth Next 5 Years %8.70
Volume Overview
Volume2.26M
Shares Outstanding727.08K
Shares Float648.34M
Trades Count43.80K
Dollar Volume558.65M
Avg. Volume2.94M
Avg. Weekly Volume2.99M
Avg. Monthly Volume3.03M
Avg. Quarterly Volume2.80M

Danaher Corporation (NYSE: DHR) stock closed at 246.37 per share at the end of the most recent trading day (a -1.13% change compared to the prior day closing price) with a volume of 2.26M shares and market capitalization of 179.13B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 69000 people. Danaher Corporation CEO is Rainer M. Blair.

The one-year performance of Danaher Corporation stock is -1.73%, while year-to-date (YTD) performance is -25.12%. DHR stock has a five-year performance of 200.82%. Its 52-week range is between 233.708 and 333.96, which gives DHR stock a 52-week price range ratio of 12.63%

Danaher Corporation currently has a PE ratio of 28.80, a price-to-book (PB) ratio of 4.20, a price-to-sale (PS) ratio of 5.92, a price to cashflow ratio of 21.70, a PEG ratio of 2.32, a ROA of 8.14%, a ROC of 10.60% and a ROE of 16.10%. The company’s profit margin is 21.32%, its EBITDA margin is 33.30%, and its revenue ttm is $30.28 Billion , which makes it $41.65 revenue per share.

Of the last four earnings reports from Danaher Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.63 for the next earnings report. Danaher Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Danaher Corporation is Strong Buy (1.5), with a target price of $330.85, which is +34.29% compared to the current price. The earnings rating for Danaher Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Danaher Corporation has a dividend yield of 0.41% with a dividend per share of $1.00 and a payout ratio of 10.00%.

Danaher Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 11.47, ATR14 : 8.51, CCI20 : -53.73, Chaikin Money Flow : -0.16, MACD : -9.25, Money Flow Index : 32.23, ROC : -4.14, RSI : 40.64, STOCH (14,3) : 48.91, STOCH RSI : 0.85, UO : 48.47, Williams %R : -51.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Danaher Corporation in the last 12-months were: Angela S. Lalor (Option Excercise at a value of $2 469 480), Angela S. Lalor (Sold 37 513 shares of value $12 266 751 ), Brian W. Ellis (Option Excercise at a value of $2 374 200), Brian W. Ellis (Sold 41 365 shares of value $12 053 247 ), Daniel A. Raskas (Option Excercise at a value of $2 269 043), Daniel A. Raskas (Sold 49 188 shares of value $16 018 732 ), Elias A. Zerhouni (Sold 3 409 shares of value $1 119 594 ), Joakim Weidemanis (Option Excercise at a value of $1 328 974), Joakim Weidemanis (Sold 55 175 shares of value $15 769 032 ), Linda Hefner Filler (Option Excercise at a value of $518 849), Linda Hefner Filler (Sold 6 733 shares of value $2 068 255 ), Matthew R. McGrew (Option Excercise at a value of $567 860), Matthew R. McGrew (Sold 14 899 shares of value $4 454 501 ), Mitchell P. Rales (Sold 1 225 841 shares of value $377 905 905 ), Robert S. Lutz (Option Excercise at a value of $289 500), Robert S. Lutz (Sold 11 006 shares of value $3 097 029 ), Teri L. List-Stoll (Option Excercise at a value of $175 735), Teri L. List-Stoll (Sold 4 548 shares of value $1 160 194 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (75.00 %)
10 (83.33 %)
12 (85.71 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (25.00 %)
2 (16.67 %)
2 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.33
Strong Buy
1.29

Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

CEO: Rainer M. Blair

Telephone: +1 202 828-0850

Address: 2200 Pennsylvania Avenue, North West, Washington 20037-1701, DC, US

Number of employees: 69 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

64%36%

Bearish Bullish

57%43%

TipRanks News for DHR

Fri, 22 Apr 2022 11:47 GMT Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Danaher (DHR) and Jazz Pharmaceuticals (JAZZ)

- TipRanks. All rights reserved.

Mon, 14 Feb 2022 18:03 GMT Danaher: Much Room for Growth When Looking Ahead

- TipRanks. All rights reserved.

Sun, 02 Jan 2022 12:05 GMT Analysts Offer Insights on Healthcare Companies: Danaher (DHR) and Landos Biopharma (LABP)

- TipRanks. All rights reserved.

News

Stocktwits